Cascade Investment Advisors’s GSK GSK Stock Holding History

Cascade Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,480	Closed	-$310K	–	230
2018 Q4	$310K	Sell	6,480 -22,072	-77%	-$1.09M	0.31%	81
2018 Q3	$1.43M	Buy	28,552 +260	+0.9%	+$13.2K	1.21%	26
2018 Q2	$1.43M	Sell	28,292 -5,116	-15%	-$258K	1.27%	23
2018 Q1	$1.63M	Buy	33,408 +3,300	+11%	+$154K	1.28%	21
2017 Q4	$1.33M	Sell	30,108 -2,088	-6%	-$96.5K	1.06%	45
2017 Q3	$1.63M	Buy	32,196 +860	+3%	+$43.6K	1.36%	19
2017 Q2	$1.69M	Sell	31,336 -240	-0.8%	-$12.8K	1.44%	18
2017 Q1	$1.66M	Buy	31,576 +784	+3%	+$39.8K	1.46%	21
2016 Q4	$1.48M	Buy	+30,792	New	+$1.52M	1.26%	35
2016 Q2	$1.44M	Buy	+26,500	New	+$1.4M	1.38%	27

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Cascade Investment Advisors's GSK Position: Q1 2019 in Review

Cascade Investment Advisors sold out of GSK (GSK) in Q1 2019, closing a stake of 6,480 shares — an estimated $310K sold.

Cascade Investment Advisors first reported a position in GSK in Q2 2016 and held it in 10 quarters. The position peaked at $1.69M in Q2 2017. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

Cascade Investment Advisors reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
Cascade Investment Advisors sold 6,480 GSK shares in Q1 2019, an estimated $310K.
Cascade Investment Advisors first reported a position in GSK in Q2 2016 and held it in 10 quarters.
Cascade Investment Advisors's GSK position peaked at $1.69M in Q2 2017.
847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on Cascade Investment Advisors's 13F filing for Q1 2019, filed 15 Apr 2019.